ASSET | DATE | % RETURN |
---|---|---|
Fubotv (FUBO) | 2/7/2017 - 2/17/2017 | 200% |
Pulse Biosciences (PLSE) | 2/7/2017 - 2/17/2017 | 96.71% |
Aehr Test Systems (AEHR) | 2/7/2017 - 2/17/2017 | 87.67% |
EVI Industries (EVI) | 2/7/2017 - 2/17/2017 | 60.07% |
Cronos (CRON) | 2/7/2017 - 2/17/2017 | 56.64% |
Esperion Therapeutics (ESPR) | 2/7/2017 - 2/17/2017 | 40.61% |
Nutex Health (NUTX) | 2/7/2017 - 2/17/2017 | 38.46% |
Editas Medicine (EDIT) | 2/7/2017 - 2/17/2017 | 37.67% |
Himax Technologies (HIMX) | 2/7/2017 - 2/17/2017 | 36.88% |
New Pacific Metals (NEWP) | 2/7/2017 - 2/17/2017 | 33.93% |
Stagwell (STGW) | 2/7/2017 - 2/17/2017 | 33.33% |
Groupon (GRPN) | 2/7/2017 - 2/17/2017 | 31.64% |
Capricor Therapeutics (CAPR) | 2/7/2017 - 2/17/2017 | 29.05% |
Syndax Pharmaceuticals (SNDX) | 2/7/2017 - 2/17/2017 | 29.03% |
Nouveau Monde Graphite (NMG) | 2/7/2017 - 2/17/2017 | 28.67% |
Galectin Therapeutics (GALT) | 2/7/2017 - 2/17/2017 | 27.83% |
Metalla Royalty & Streaming (MTA) | 2/7/2017 - 2/17/2017 | 27.63% |
Western Copper and Gold (WRN) | 2/7/2017 - 2/17/2017 | 27.2% |
LightPath Technologies (LPTH) | 2/7/2017 - 2/17/2017 | 26.29% |
NioCorp Developments Ltd Common Stock (NB) | 2/7/2017 - 2/17/2017 | 25.68% |
DiaMedica Therapeutics (DMAC) | 2/7/2017 - 2/17/2017 | 24.9% |
Transcontinental Realty Investors (TCI) | 2/7/2017 - 2/17/2017 | 24.82% |
AnaptysBio (ANAB) | 2/7/2017 - 2/17/2017 | 23.59% |
XOMA (XOMA) | 2/7/2017 - 2/17/2017 | 23.19% |
Benitec Biopharma Ltd ADR (BNTC) | 2/7/2017 - 2/17/2017 | 22.98% |